Pre-induction Analgesia: Multimodel Regimen vs Aceteminophen for Post Ureteroscopy Pain

• Status: Withdrawn
• Trial end date: 2019-06-30
• Target enrollment: 0
• Participant gender: All

Summary

Adult patients with kidney stones undergoing surgical intervention with ureteroscopy with laser lithotripsy will be randomized to receive one of two different regimens of oral medications administered prior to induction of general anesthesia. Postoperatively, patients will receive automated daily text messages to assess pain and opioid consumption and subsequently determine which which treatment regimen is superior.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kevin J Flynn MD
• Treatments: Acetaminophen; Celecoxib; Gabapentin; Oxycodone

Criteria

Inclusion Criteria:

• Adult Patient (greater than 18 years old)

• Possesses or has access to cell phone with text message capability

• Undergoing ureteroscopy with lithotripsy for a ureteral or kidney stones

Exclusion Criteria:

• Does not possess or have access to a cell phone with text message capability

• Non-English speaking

• Incarcerated individuals

• undergoing planned secondary procedure

• pregnancy

• intellectual disability

• History of, anaphylactic, rash, or other hypersensitivity reaction to any of the study agents

• Patients with history of CABG, myocardial infarction, endovascular cardiac stent, gastrointestinal bleed, or gastric ulcer disease will not receive Celecoxib. They may still participate in the study otherwise, it will be documented that they did not receive an NSAID component.